Related Experiment Videos
Determination of hyperforin in human plasma using solid-phase extraction and high-performance liquid chromatography
Yanyan Cui1, Bill Gurley, Catharina Y W Ang
1Division of Chemistry, National Center for Toxicological Research, US Food and Drug Administration, HFT-230, 3900 NCTR Road, Jefferson, AR 72079, USA.
Summary
This study developed a rapid and sensitive method to measure hyperforin, a key compound in St. John's wort, in human plasma. The validated technique allows for accurate quantification of hyperforin levels, aiding depression treatment research.
Area of Science:
- Pharmacology
- Analytical Chemistry
- Natural Products
Background:
- St. John's wort (Hypericum perforatum) is a botanical supplement used for mild to moderate depression.
- Hyperforin is a primary active constituent responsible for the therapeutic effects of St. John's wort.
Purpose of the Study:
- To develop and validate a method for quantifying hyperforin in human plasma.
- To enable pharmacokinetic studies of St. John's wort.
Main Methods:
- Solid-phase extraction (SPE) for sample preparation.
- Isocratic high-performance liquid chromatography (HPLC) with UV detection.
- Use of Benzo[k]fluoranthene as an internal standard.
Main Results:
- High absolute recovery (>89%) for hyperforin in plasma.
- Linear calibration curves and acceptable inter-day/intra-day variability.
- Sensitive detection with a limit of detection (LOD) of 4 ng/ml and limit of quantitation (LOQ) of 10 ng/ml.
Conclusions:
- The developed SPE-HPLC-UV method is rapid, sensitive, and reproducible.
- The method is suitable for quantitative analysis of hyperforin in human plasma.
- This supports further research into St. John's wort efficacy and pharmacokinetics.